The latest research study “Medical Foods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” The global medical foods market reached a value of US$ 20.69 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.18 Billion by 2027, exhibiting a CAGR of 5.80% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Medical Foods Industry Definition and Application:
Medical foods are intended for the dietary management of a disease, which cannot be met through a normal diet alone. They are prepared for the partial or exclusive feeding of the patient through oral intake or enteral feeding by tube under the supervision of a medical specialist. They are formulated under the supervision of a physician according to scientific principles and medical evaluation. They are composed of food additives, color additives, and a combination of vitamins, minerals, and botanicals for better dietary management. Medical foods support the therapeutic effects of the drug and offer an effective therapeutic tool for managing pain, sleep, and cognitive disorders. Presently, they are available in pills, liquid, and powder forms across the globe.
Download free sample brochure: https://www.imarcgroup.com/medical-foods-market/requestsample
Global Medical Foods Market Industry Trends and Drivers:
At present, the growing global geriatric population and increasing cases of medical ailments, such as cancer, attention-deficit or hyperactivity disorder (ADHD), depression, diabetes, cancer, and Alzheimer’s, represent one of the key factors positively influencing the market. In line with this, the rising prevalence of metabolic and gastrointestinal diseases due to sedentary lifestyles is catalyzing the demand for medical foods. Moreover, the development in the healthcare sector and the introduction of favorable initiatives for the manufacturing of medical foods to meet the specific requirement of patients are currently bolstering the growth of the market. Additionally, the easy availability of medical foods in grocery stores and pharmacies is creating a positive market outlook. In line with this, rapid digitization, increasing sales of smartphones, and the rising penetration of high-speed internet are contributing to the increasing sales of medical foods through e-commerce platforms.
Moreover, the widespread adoption of natural sources, bioactive compounds, and food rich in phytochemicals for manufacturing medical foods is supporting the market growth. Besides this, as medical foods aid in boosting the immune and digestive systems of individuals, they are gaining immense traction across the globe. Furthermore, inflating income levels and changing dietary patterns worldwide are creating a favorable market outlook. Additionally, stringent government guidelines are encouraging investors in efficient production and effective maintenance of the product. Specific emphasis on nutritional requirements adhering to clinical guidelines is positively influencing the market. Apart from this, the growing research and development (RD) activities to offer novel medical food products, fulfill the nutritional demand of consumers, and enhance the shelf-life of food items without compromising on their taste and nutritional values are anticipated to drive the market in the coming years.
The report has been segmented the market into following categories:
Breakup by Component:
Breakup by Route of Administration:
Breakup by Application:
- Alzheimer’s Disease
- Metabolic Disorders
Breakup by Distribution Channel:
- Hospital and Retail Pharmacies
- Online Pharmacies
- North America
- United States
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
List of Major Key Players:
- Abbott Healthcare Private Limited
- Alfasigma S.p.A.
- Danone S.A.
- Fresenius Kabi AG
- Mead Johnson & Company LLC (Reckitt Benckiser)
- Medtrition Inc.
- Meiji Holdings Co. Ltd.
- Metagenics Inc. (Alticor)
- Nestlé S.A.
- Primus Pharmaceuticals Inc.
- Targeted Medical Pharma Inc., and Victus Inc
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3637&flag=C
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel NoD) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800